Good MorningThe equities market started the week with a whimper. The S&P 500 gained less than a tenth of a percentage point at the high of the day but did set a new all-time high record. The move comes just days before the peak of the S&P 500 earnings reporting season and is a sign of high expectation regarding the results. The risk for the market now is that Q1 growth is already priced into stocks which is a situation that could lead to a sell-off.
This week’s earnings reports come from a broad array of sectors but the focus will be on the financials. The financials are the new bellwethers and will set the tone for the season. Topping the list of names are J.P. Morgan Chase, Goldman Sachs, Morgan Stanley, Bank of America, and Citigroup. Also of note will be earnings reports from transportation leader J.B. Hunt, consumer staples giant Pepsico, and Alcoa.
Featured: New Pentagon rules set to reshape critical mineral supply chains (Ad) 
|
Technology | | By now, we’re all familiar with the theme of pandemic lockdowns boosting business among digital sales platforms, such as Shopify (NYSE: SHOP), Etsy (NASDAQ: ETSY) and Fiverr (NYSE: FVRR).
Not only were people shopping more from home, as retailers closed down or limited their capacity, especi... Read the Full Story |
|
From Our Partners | | Barrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldrush, and Cortez Hills, deposits that could hold up to 60 million ounces of gold.
One overlooked explorer controls 142 claims bordering Fourmile and sitting less than a mile from Goldrush. New geological modeling aims to reveal what's beneath this largely untested ground, while a planned 5% royalty spin-off could give shareholders a separate stake in the project. | | Read the full report before the next catalyst hits |
|
Industrials | | Sometimes, you have a company like Uber (NYSE:UBER) that comes along and creates an innovative product or service which makes it difficult to imagine what life was like before it. If you aren’t familiar with this company, Uber provides a ridesharing application that offers a quick and convenie... Read the Full Story |
|
Markets | |
Concrete and aggregate products maker U.S. Concrete (NASDAQ: USCR) stock has been on a tear thanks to the housing boom and tailwinds created by the Biden infrastructure bill. The stock has benefited as both a pandemic benefactor from housing and re-opening play with infrastructure spending. Constr... Read the Full Story |
|
From Our Partners | | Trader Chris Pulver says a new SEC document dropping the day-trading limit to $2,000 has created the biggest retail opportunity he has seen in over 30 years.
His strategy targets what he calls Flashpoints - moments when market makers must move billions of dollars on the S-P 500 in a narrow window. Research shows one recent signal would have returned 83.7% in 36 minutes and another 62.8% in 51 minutes.
Lance Ippolito flew to Utah for a full breakdown of the method. | | Tap here to see the complete Flashpoint trading breakdown now |
|
Industrials | | Delta Air Lines (NYSE:DAL) will kick-off the much-anticipated earnings season for airlines on April 15. But DAL stock is experiencing some turbulence as it prepares to report earnings.
However, in fairness, the stock has been having an uneven recovery. If you had bought DAL stock at the beginning o... Read the Full Story |
|
Industrials | |
Good News Not Good Enough For Fastenal
Fastenal (NASDAQ: FAST) reported a decent FQ1 but the report is a great example of what we have begun to fear in the market. The results were completely as expected, margins are under pressure, and costs are rising throughout the supply chain. Granted, this... Read the Full Story |
|
From Our Partners | | A 60-minute morning window is catching traders' attention for one reason: it doesn't depend on market direction.
Place a quick trade before 10 am, then step away. Sixty minutes later, the setup has already done its work.
The strategy targets a 50 percent return potential on a $1,000 stake, though results vary and some trades won't work out. | | Discover how to apply this 60 minute trading window today |
|
Consumer Discretionary | |
A 3.5% pop on Monday had shares of Tesla (NASDAQ: TSLA) right around their short-term resistance level of $710. They’ve been consolidating below there for the past month after selling off sharply in February and look ripe for a breakthrough. The catalyst for the 40% drop was the sudden uptic... Read the Full Story |
|
Technology | |
U.S. semiconductor developer Intel (NASDAQ: INTC) stock has staged a rally back towards its 2019 pre-pandemic highs to set-up either a double-top or a breakout. With a long-awaited new CEO, Pat Gelsinger, installed and with plans to build chip fabrication (FABs) plants directly in the U.S. changes... Read the Full Story |
|
Finance | |
BlackRock (NYSE: BLK) is set to report its first-quarter earnings on Thursday; the largest asset manager in the world launched two new Environmental, Social, and Governance (ESG) ETFs on Thursday, showing where its focus lies ahead of the earnings release.
The asset manager wasn’t always on... Read the Full Story |
|
Healthcare | | Back in the late 1990's Simulations Plus (NASDAQ:SLP) was a small-cap health care software stock trading below $10. Today, it is a $1.2 billion company and an up-and-coming leader in a space that is ripe for multiyear growth.
Simulations Plus is capitalizing on increasing global demand for software... Read the Full Story |
|
Consumer Discretionary | |
EV's Take Market Share In China
The latest data out of China shows that not only is China's auto market back to pre-pandemic levels but the EV market continues to take share. Data from China's Passenger Car Association show sales of passenger vehicles in the nation grew 70% in the first quarter ... Read the Full Story |
|
The Early Bird Stock Of The Day Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. As of December 14, 2023, Seagen Inc. operates as a subsidiary of Pfizer Inc. | | View Today's Stock Pick |
|
